PSB-10
| Identifikatori | |
|---|---|
| ATC kod | none |
| Sinonimi | PSB-10 |
PSB-10 je lek koji deluje kao selektivan inverzni agonist[1] za adenozinski A3 receptor, sa visokom selektivnošću u odnosu na druga tri tipa adenozinskih receptora. Pokazano je da proizvodi antiinflamatorne efekte u životinjskim studijama.[2][3]
Reference
- ^ Hallmen C, Wiese M (2006). „Molecular dynamics simulation of the human adenosine A3 receptor: agonist induced conformational changes of Trp243”. Journal of Computer-aided Molecular Design. 20 (10-11): 673—84. PMID 17124628. doi:10.1007/s10822-006-9088-5.
- ^ Bilkei-Gorzo A, Abo-Salem OM, Hayallah AM, Michel K, Müller CE, Zimmer A (2008). „Adenosine receptor subtype-selective antagonists in inflammation and hyperalgesia”. Naunyn-Schmiedeberg's Archives of Pharmacology. 377 (1): 65—76. PMID 18188542. doi:10.1007/s00210-007-0252-9.
- ^ Müller CE (2003). „Medicinal chemistry of adenosine A3 receptor ligands”. Current Topics in Medicinal Chemistry. 3 (4): 445—62. PMID 12570761. doi:10.2174/1568026033392174. Архивирано из оригинала 14. 04. 2013. г. Приступљено 09. 10. 2018.
Spoljašnje veze
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.